Evidence map›Paper›PMID 35534221›Full record

ArticleInvestigative and clinical urology2022

A new strategy for stem cells therapy for erectile dysfunction: Adipose-derived stem cells transfect Neuregulin-1 gene through superparamagnetic iron oxide nanoparticles.

Jianxing Cheng, Zhongjie Zheng, Wenhao Tang, Jichun Shao, Hui Jiang, Haocheng Lin

Open access · diamondAbstract read
In one paragraph

Article in Investigative and clinical urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Research Advances in Stem Cell Therapy for Erectile Dysfunction.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2024
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jianxing ChengDepartment of Urology, Peking University Third Hospital, Peking University, Beijing, China.ORCID 0000-0003-3860-8479
Zhongjie ZhengDepartment of Urology, Peking University Third Hospital, Peking University, Beijing, China.ORCID 0000-0002-5519-9809
Wenhao TangDepartment of Urology, Peking University Third Hospital, Peking University, Beijing, China.ORCID 0000-0002-6591-6584
Jichun ShaoDepartment of Urology, Second Affiliated Hospital of Chengdu Medical College (China National Nuclear Corporation 416 Hospital), Chengdu, Sichuan, China.ORCID 0000-0002-0947-7820
Hui JiangDepartment of Urology, Peking University Third Hospital, Peking University, Beijing, China.ORCID 0000-0002-5417-2356
Haocheng LinDepartment of Urology, Peking University Third Hospital, Peking University, Beijing, China.ORCID 0000-0002-5333-6611
Peking University · CNChina National Nuclear Corporation · CN

Funding

National Key Research and Developmental Program of China 2018YFC1003600National Natural Science Foundation of China #81601272Natural Science Foundation of Beijing Municipality General #7212134Peking University Clinical Medicine+X Youth Special Program PKU #2018LCXQ019
6 · The paper itself

Abstract

purposeOur previous studies showed that nanotechnology improves derived adipose-derived stem cells (ADSCs) therapy for erectile dysfunction (ED). In this study, the Neuregulin-1(NRG1) gene was transfected into ADSCs with superparamagnetic iron oxide nanoparticles (SPION) further to improve the therapeutic effect of ADSCs on ED. MATERIALS AND

methodsADSCs were isolated from epididymal adipose tissue of Sprague-Dawley rats. The optimal concentration of PEI-SPION (SPION modified with polyethyleneimine) was selected to construct the gene complex. After electrostatic binding of PEI-SPION and DNA, a PEI layer was wrapped to make the PEI-SPION-NRG1-PEI gene transfection complex. Different groups were set up for transfection tests. Lipo2000 transfection reagent was used as the control. PEI-SPION-NRG1-PEI in the experimental group was transfected under an external magnetic field.

resultsWhen the concentration of PEI-SPION was 10 µg/mL, it had little cytotoxicity, and cell activity was not significantly affected. PEI-SPION-NRG1-PEI forms positively charged nanocomposites with a particle size of 72.6±14.9 nm when N/P ≥8. The PEI-SPION-NRG1-PEI gene complex can significantly improve the transfection efficiency of ADSCs, reaching 26.74%±4.62%, under the action of the external magnetic field. PCR and Western blot showed that the expression level of the NRG1 gene increased significantly, which proved that the transfection was effective.

conclusionsPEI-SPION can be used as a vector for NRG1 gene transfection into ADSCs. PEI-SPION-NRG1-PEI packaging has the highest transfection efficiency under the external magnetic field than the other groups. These findings may provide a new strategy for ADSCs therapy for ED.

Indexed as

Erectile DysfunctionAdipose TissueAnimalsHumansMagnetic Iron Oxide NanoparticlesMaleNeuregulin-1RatsRats, Sprague-DawleyStem CellsNeuregulin-1Adipose-derived mesenchymal stem cellsErectile dysfunctionNeuregulin-1Superparamagnetic iron oxide nanoparticlesTransfections

Identifiers

PMID35534221
PMCPMC9091825
OpenAlexW4226157906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.